Te­va set­tles with Louisiana for $18M over opi­oid claims; Video game treat­ment churns out PhII re­sults

Te­va Phar­ma­ceu­ti­cals is pay­ing the state of Louisiana $15 mil­lion in cash over the next 18 years, in ex­change for be­ing re­leased from law­suits over the state’s opi­oid claims.

As part of the agree­ment, Te­va will al­so do­nate $3 mil­lion in opi­oid ad­dic­tion re­cov­ery drugs — con­tin­gent up­on be­ing re­leased from all Louisiana law­suits by Nov. 2.

As the US-based sub­sidiary for Is­rael’s Te­va Phar­ma­ceu­ti­cal In­dus­tries, Te­va has been fac­ing le­gal pro­ceed­ings in a num­ber of US states, in­clud­ing New York and Cal­i­for­nia, amid claims that the com­pa­ny en­gaged in mis­lead­ing mar­ket­ing of opi­oids and down­played the risks of opi­oid ad­dic­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.